Plasmodium falciparum haem polymerization

Plasmodium falciparum haem polymerization is a vital detoxification process occurring within the acidic food vacuole of the malaria parasite during its intraerythrocytic developmental stage. As the parasite digests host hemoglobin to obtain essential amino acids, it releases free haem (ferriprotoporphyrin IX), which is highly toxic due to its ability to generate reactive oxygen species and disrupt cellular membranes (Sullivan, 2002, PMID: 12435805). To survive, the parasite polymerizes this toxic free haem into an insoluble, chemically inert crystalline pigment known as hemozoin or β-haematin (Egan, 2008, PMID: 18624473). This pathway serves as the primary target for several major classes of antimalarial drugs, most notably the quinolines such as chloroquine and quinine. These drugs function by binding to the haem monomers or the growing crystal faces of hemozoin, thereby preventing further polymerization. The resulting accumulation of toxic free haem leads to the rapid death of the parasite through oxidative damage and vacuolar membrane disruption (Hempelmann, 2007, PMID: 17343618). While this target has been historically effective, the global emergence of resistance—primarily driven by mutations in the Plasmodium falciparum chloroquine resistance transporter (PfCRT)—has significantly complicated treatment efforts (Fidock et al., 2000, PMID: 11039928). Understanding the biophysical mechanisms of haem polymerization remains essential for the development of next-generation antimalarials capable of overcoming existing resistance mechanisms.

Other names

Hemozoin formationβ-haematin crystallizationHeme detoxification pathwayHaem sequestration

Inhibition of the biocrystallization of toxic monomeric haem (ferriprotoporphyrin IX) into non-toxic, insoluble hemozoin crystals, leading to the accumulation of free haem which causes oxidative stress and membrane lysis within the parasite food vacuole (Combrinck et al., 2013, PMID: 23530019).